Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Willow Biosciences is a biotechnology company that develops and produces high-purity, plant-derived ingredients for the global health and wellness, food and beverage, and personal care markets. Using its proprietary FutureGrown platform, the company employs yeast-based fermentation to create sustainable and cost-effective functional ingredients, including cannabinoids like CBG and other high-value molecules such as astaxanthin. Willow's technology enables the production of ingredients that are traditionally difficult to source from nature, providing a consistent and scalable supply for its partners in the pharmaceutical and consumer goods industries. The company is focused on commercializing its pipeline of biosynthetic products while expanding its platform to include a broader range of functional ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Willow Wellness.